Chemed Corporation (NYSE:CHE) Given Consensus Rating of “Moderate Buy” by Brokerages

Chemed Corporation (NYSE:CHE) has earned an average recommendation of “Moderate Buy” from the six research firms that are presently covering the stock, MarketBeat Ratings reports. Two analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is $574.25.

A number of brokerages have recently commented on CHE. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Chemed in a report on Wednesday, October 8th. Royal Bank Of Canada dropped their price target on Chemed from $589.00 to $572.00 and set an “outperform” rating on the stock in a research report on Monday, November 10th. Finally, Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a research report on Thursday, October 30th.

Insider Transactions at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction on Monday, November 24th. The shares were sold at an average price of $437.55, for a total transaction of $875,100.00. Following the completion of the transaction, the chief executive officer owned 94,197 shares in the company, valued at approximately $41,215,897.35. This represents a 2.08% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 3.29% of the company’s stock.

Institutional Trading of Chemed

Several hedge funds and other institutional investors have recently made changes to their positions in CHE. Geneos Wealth Management Inc. raised its holdings in Chemed by 330.4% during the first quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock worth $61,000 after purchasing an additional 76 shares in the last quarter. Strs Ohio acquired a new position in Chemed during the first quarter worth about $1,681,000. Voya Investment Management LLC lifted its position in shares of Chemed by 1.5% during the 1st quarter. Voya Investment Management LLC now owns 2,645 shares of the company’s stock valued at $1,628,000 after acquiring an additional 40 shares during the period. Parallel Advisors LLC boosted its stake in shares of Chemed by 4.8% during the 2nd quarter. Parallel Advisors LLC now owns 705 shares of the company’s stock worth $343,000 after acquiring an additional 32 shares in the last quarter. Finally, Gallacher Capital Management LLC acquired a new stake in shares of Chemed in the 2nd quarter worth approximately $227,000. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Chemed Trading Down 1.4%

CHE stock opened at $452.40 on Friday. The company has a market capitalization of $6.41 billion, a P/E ratio of 23.92, a PEG ratio of 2.20 and a beta of 0.44. The business has a 50 day simple moving average of $435.69 and a 200-day simple moving average of $444.04. Chemed has a twelve month low of $408.42 and a twelve month high of $623.60.

Chemed (NYSE:CHE) last announced its earnings results on Tuesday, October 28th. The company reported $5.27 EPS for the quarter, missing analysts’ consensus estimates of $5.39 by ($0.12). The business had revenue of $624.90 million during the quarter, compared to analyst estimates of $626.04 million. Chemed had a net margin of 11.02% and a return on equity of 25.89%. The business’s revenue was up 3.1% compared to the same quarter last year. During the same period in the previous year, the firm earned $5.64 earnings per share. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. Research analysts predict that Chemed will post 21.43 EPS for the current fiscal year.

Chemed Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, December 5th. Investors of record on Monday, November 17th were issued a dividend of $0.60 per share. The ex-dividend date of this dividend was Monday, November 17th. This represents a $2.40 annualized dividend and a dividend yield of 0.5%. Chemed’s dividend payout ratio (DPR) is currently 12.69%.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.